Start Date
February 15, 2022
Primary Completion Date
May 15, 2023
Study Completion Date
May 15, 2023
IND/GLY/MF
Prospective observational cohort study. There is no treatment allocation. Patients will be invited to participate in the study when attending participating community pharmacies with a first prescription of IND/GLY/MF with sensor or IND/GLY/MF without sensor
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY